3M and Zargis Announce Global Marketing Alliance
October 25 2007 - 11:40AM
PR Newswire (US)
ST. PAUL, Minn. and PRINCETON, N.J., Oct. 25 /PRNewswire/ -- 3M and
Zargis Medical Corp., a spin-off from Siemens Corporate Research
(NYSE:SI) and a majority-owned subsidiary of Speedus Corp.
(NASDAQ:SPDE) today announced an exclusive multi-year marketing
agreement involving Zargis' heart sound analysis software and 3M
Littmann's next-generation electronic stethoscope. Under the
agreement, Zargis will support 3M in its efforts to develop a
next-generation stethoscope that will be compatible with Zargis'
heart sound analysis software. The date on which Zargis' software
will become available for use with a Littmann stethoscope has not
yet been announced. "This agreement builds on the rich Littmann
brand legacy of advancing the art of auscultation," said Chuck
Kummeth, Vice President and General Manager, 3M Medical Division.
"We are committed to bringing innovative solutions to our
customers, and this agreement with Zargis will help us do this well
into the future." "We have been working closely with 3M for nearly
two years to further evaluate this market and refine our product
strategy," stated Zargis CEO John Kallassy. "We believe that the
use of our software could enhance the physician experience during
every patient exam where a stethoscope is currently used. This
alliance with 3M will allow us to seamlessly integrate our advanced
sound analysis technology with 3M's next-generation electronic
stethoscopes and turn this vision into a reality on a global
level." In addition, the alliance provides Zargis with a wide-range
of marketing and promotional opportunities along with exclusive
rights to sell its ground- breaking heart sound analysis software
through the global distribution network of the Littmann brand. The
agreement grants 3M a minority equity position in Zargis, following
the first sale of Zargis' software through the 3M distribution
channel, and a seat on Zargis' board of directors. Tom Miller,
member of Siemens Medical's Executive Management Board, stated, "We
are very encouraged by this agreement and the progress Zargis has
made since it spun off from Siemens Corporate Research and we look
forward to continuing our support and seeing their business
mature." About 3M HealthCare 3M HealthCare, one of 3M's six major
business segments, provides world- class innovative products and
services to healthcare professionals to improve the practice,
delivery and outcome of patient care in medical, oral care, drug
delivery and health information markets. About 3M -- A Global,
Diversified Technology Company Every day, 3M people find new ways
to make amazing things happen. Wherever they are, whatever they do,
the company's customers know they can rely on 3M to help make their
lives better. 3M's brands include Scotch, Post-it, Scotchgard,
Thinsulate, Scotch-Brite, Filtrete, Command and Vikuiti. Serving
customers around the world, the people of 3M use their expertise,
technologies and global strength to lead in major markets including
consumer and office; display and graphics; electronics and
telecommunications; safety, security and protection services;
health care; industrial and transportation. Littmann, Scotch,
Post-it, Scotchgard, Thinsulate, Scotch-Brite, Filtrete, Command
and Vikuiti are trademarks of 3M. For more information, including
the latest product and technology news, visit http://www.3m.com/.
About Zargis Medical Corp. Zargis Medical Corp. develops advanced
diagnostic decision support products and services for primary care
physicians, pediatricians, cardiologists and other healthcare
professionals. Zargis was formed in 2001 when Siemens Corporate
Research, a division of Siemens AG (NYSE:SI), and Speedus Corp.
co-invested to develop and market an advanced acoustic technology
designed to detect heart abnormalities identified through analysis
of heart sounds. About Siemens Siemens AG (NYSE:SINYSE:-NYSE:News)
is one of the largest global electronics and engineering companies
with reported worldwide sales of $107.4 billion in 2006. Founded
160 years ago, the company is a leader in the areas of Medical,
Power, Automation and Control, Transportation, Information and
Communications, Lighting, Building Technologies, Water Technologies
and Services and Home Appliances. With its U.S. corporate
headquarters in New York City, Siemens in the USA has sales of
$21.4 billion and employs approximately 70,000 people throughout
all 50 states and Puerto Rico. Eleven of Siemens' worldwide
businesses are based in the United States. With its global
headquarters in Munich, Siemens AG and its subsidiaries employ
480,000 people in 190 countries. For more information on Siemens in
the United States: http://www.usa.siemens.com/. For additional
information about Zargis or Speedus Corp., contact Peter Hodge at
888.773.3669 (ext. 23) or or visit the following Web sites:
http://www.zargis.com/ and http://www.speedus.com/. Statements
contained herein about Zargis that are not historical facts,
including but not limited to statements about Zargis' product,
corporate identity and focus, may be forward-looking statements
that are subject to a variety of risks and uncertainties. There are
a number of important factors that could cause actual results to
differ materially from those expressed in any forward-looking
statements made by Zargis, including, but not limited to, the
continuing development of Zargis' sales, marketing and support
efforts. Zargis Contact: Peter Hodge (888) 773-3669 Ext. 23 3M
Contact: Stephanie Sanderson (651) 733-8588 DATASOURCE: Zargis
Medical Corp.; 3M CONTACT: Peter Hodge, Zargis, 888-773-3669 Ext.
23, , or Stephanie Sanderson, 3M, +1-651-733-8588, Web site:
http://www.speedus.com/ http://www.zargis.com/
http://w1.siemens.com/ http://www.3m.com/
Copyright
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Jul 2023 to Jul 2024